Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2023
DOI: 10.3390/molecules28020577
|View full text |Cite
|
Sign up to set email alerts
|

Development of in-House Synthesis and Quality Control of [99mTc]Tc-PSMA-I&S

Abstract: Many radioactive PSMA inhibitory substances have already been developed for PET diagnostics and therapy of prostate cancer. Because PET radionuclides and instrumentation may not be available, technetium-99 m labelled tracers can be considered as a diagnostic alternative. A suitable tracer is [99mTc]Tc-PSMA-I&S, primarily developed for radio-guided surgery, which has been identified for diagnostics of prostate cancer. However, there is no commercial kit approved for the preparation of [99mTc]Tc-PSMA-I&S… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 13 publications
0
5
0
Order By: Relevance
“…8 However, it was prepared in the presence of the [ 99m Tc(CO) 3 (H2O) 3 ] + has been explored in a kit formulation for PSMA-targeted radioguided surgery, which is available for routine production and entered a phase II study (NCT04832958). 17 This promising agent has several shortcomings, including slow washout from the blood pool and prolonged retention in the kidneys, liver, and intestines. As a bifunctional chelator of 99m Tc, HYNIC is considered an efficient labeling platform for the formation of stable 99m Tc complexes with high RCY.…”
Section: ■ Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…8 However, it was prepared in the presence of the [ 99m Tc(CO) 3 (H2O) 3 ] + has been explored in a kit formulation for PSMA-targeted radioguided surgery, which is available for routine production and entered a phase II study (NCT04832958). 17 This promising agent has several shortcomings, including slow washout from the blood pool and prolonged retention in the kidneys, liver, and intestines. As a bifunctional chelator of 99m Tc, HYNIC is considered an efficient labeling platform for the formation of stable 99m Tc complexes with high RCY.…”
Section: ■ Discussionmentioning
confidence: 99%
“…However, it was prepared in the presence of the [ 99m Tc­(CO) 3 (H2O) 3 ] + intermediate and purified by radio-HPLC, which is an obstacle to its wider use in clinical practice. Based on the [ 99m Tc]­[TcO] 3+ core, [ 99m Tc]­Tc-PSMA-I&S (imaging and surgery) has been explored in a kit formulation for PSMA-targeted radioguided surgery, which is available for routine production and entered a phase II study (NCT04832958) . This promising agent has several shortcomings, including slow washout from the blood pool and prolonged retention in the kidneys, liver, and intestines.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, (de)hydrogenation and (de)hydration are beyond the scope of this review, and readers are directed to a recently published excellent review for these transformations. 11 Additionally, while N,C′-chelation of these heterocycles is feasible, the discussion is centered around N,N′-chelation, which is crucial for most of the reported catalytic activities.…”
Section: Figure 1 Representative Pyrazolopyridine-containing Organome...mentioning
confidence: 99%
“…Moreover, the potential of PzPy ligands has been explored in hydrogenation and dehydrogenation reactions. 11 Nonetheless, their application in facilitating the formation of C-C and C-heteroatom bonds has only come to the forefront in recent years.…”
Section: Introductionmentioning
confidence: 99%